Stress Cardiomyopathy (Takotsubo Cardiomyopathy)

S. S. Yashin; A. O. Kireeva; P. A. Sukhachev

doi:10.35401/2541-9897-2023-26-1-111-115

Stress Cardiomyopathy (Takotsubo Cardiomyopathy)

S. S. Yashin, A. O. Kireeva, P. A. Sukhachev

https://doi.org/10.35401/2541-9897-2023-26-1-111-115

Full Text:

PDF (Rus) |

Generate QR code

Abstract

In this article we describe a rare clinical condition of stress cardiomyopathy (takotsubo cardiomyopathy) for which we, despite controversy and lack of data, identified the main pathogenic pathways (including the direct toxic effect of catecholamines on the myocardium, catecholamine-mediated myocardial stunning, and microcirculation disorders). After the systematic review, we identified the distinct pathology features of this condition and new diagnostic strategies.

Keywords

takotsubo cardiomyopathy, stress cardiomyopathy, takotsubo syndrome, apical ballooning syndrome

References

1. Zhang Z, Jin S, Teng X, Duan X, Chen Y, Wu Y. Hydrogen sulfide attenuates cardiac injury in takotsubo cardiomyopathy by alleviating oxidative stress. Nitric Oxide. 2017;67:10-25. PMID: 28450188. https://doi.org/10.1016/j.niox.2017.04.010

2. Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 2008;5(1):22-29. PMID: 18094670. https://doi.org/10.1038/ncpcardio1066

3. Nakano T, Onoue K, Nakada Y, et al. Alteration of β-adrenoceptor signaling in left ventricle of acute phase takotsubo syndrome: a human study. Sci Rep. 2018;8(1):12731. PMID: 30143703. PMCID: PMC6109068. https://doi.org/10.1038/s41598018-31034-z

4. Kakturskiy LV, Mikhaleva LM, Mishnev OD, Zayratyants OV, Kurilina EV, Komlev AE. Takotsubo syndrome (stress-induced cardiomyopathy). Arkh Patol. 2021;83(1):5-11. (In Russ.). PMID: 33512121. https://doi.org/10.17116/patol2021830115

5. Shilova AS, Shmotkina AO, Yafarova AA, Gilyarov MYu. Takotsubo syndrome: contemporary views on the pathogenesis, prevalence and prognosis. Rational Pharmacotherapy in Cardiology. 2018;14(4):598-604. (In Russ). https://doi.org/10.20996/18196446-2018-14-4-598-604

6. Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the “broken heart syndrome”. Clin Res Cardiol. 2009;98(7):457-462. PMID: 19513776. https://doi.org/10.1007/s00392-009-0028-y

7. Exner DV, Birnie DH, Moe G, et al. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection. Can J Cardiol. 2013;29(2):182-195. PMID: 23351926. https://doi.org/10.1016/j.cjca.2012.10.006

8. Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8-27. https://doi.org/10.1002/ejhf.424

9. Matveeva MG, Gogin GE, Alekhin MN. Takotsubo cardiomyopathy: case report. Clinical Medicine (Russian Journal). 2017; 95(7):663-668. (In Russ.). https://doi.org/10.18821/0023-21492017-95-7-663-668

10. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14(9):1137-1149. PMID: 19158054. https://doi.org/10.4158/ep.14.9.1137

11. Mitchell A, Marquis F. Can takotsubo cardiomyopathy be diagnosed by autopsy? Report of a presumed case presenting as cardiac rupture. BMC Clin Pathol. 2017;17:4. PMID: 28396614. PMCID: PMC5382367. https://doi.org/10.1186/s12907-017-0045-0

12. Caforio AL, Tona F, Vinci A, et al. Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail. 2009;11(4):428-431. PMID: 19193625. https://doi.org/10.1093/eurjhf/hfp008

13. Dalia T, Amr BS, Agrawal A, Gautam A, Sethapati VR, Kvapil J. A rare case of sudden death in a patient with takotsubo cardiomyopathy secondary to cardiac rupture. Case Rep Cardiol. 2019;2019:5404365. PMID: 31428481. PMCID: PMC6683796. https://doi.org/10.1155/2019/5404365

14. Kumar S, Kaushik S, Nautiyal A, et al. Cardiac rupture in takotsubo cardiomyopathy: a systematic review. Clin Cardiol. 2011;34(11):672-676. PMID: 21919012. PMCID: PMC6652409. https://doi.org/10.1002/clc.20957

15. Sung BH, Ching M, Izzo JL Jr, Dandona P, Wilson MF. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women. J Hypertens. 1999;17(4):523-528. PMID: 10404954. https://doi.org/10.1097/00004872-19991704000010

16. Pasupathy S, Tavella R, Beltrame JF. Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management. Circulation. 2017;135(16):1490-1493. https://doi.org/10.1161/circulationaha.117.027666

17. Buja P, Zuin G, Di Pede F, et al. Long-term outcome and sex distribution across ages of left ventricular apical ballooning syndrome. J Cardiovasc Med (Hagerstown). 2008;9(9):905-909. PMID: 18695427. https://doi.org/10.2459/jcm.0b013e3282fec072

18. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50(5):448-452. PMID: 17662398. https://doi.org/10.1016/j.jacc.2007.03.050

19. Chadha S. ‘COVID-19 pandemic’ anxiety-induced Takotsubo cardiomyopathy. QJM. 2020;113(7):488-490. PMID: 32311043. PMCID: PMC7188117. https://doi.org/10.1093/qjmed/hcaa135

20. Wilson HM, Cheyne L, Brown PAJ, et al. Characterization of the myocardial inflammatory response in acute stressinduced (Takotsubo) cardiomyopathy. JACC Basic Transl Sci. 2018;3(6):766-778. PMID: 30623136. PMCID: PMC6314973. https://doi.org/10.1016/j.jacbts.2018.08.006

For citations:

Yashin S.S., Kireeva A.O., Sukhachev P.A. Stress Cardiomyopathy (Takotsubo Cardiomyopathy). Innovative Medicine of Kuban. 2023;(1):111-115. (In Russ.) https://doi.org/10.35401/2541-9897-2023-26-1-111-115

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 2541-9897 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

Innovative Medicine of Kuban

Stress Cardiomyopathy (Takotsubo Cardiomyopathy)

Full Text:

Abstract

Keywords

About the Authors

References

Review

For citations:

User

Innovative Medicine of Kuban

Stress Cardiomyopathy (Takotsubo Cardiomyopathy)

Full Text:

Abstract

Keywords

About the Authors

References

Review

For citations:

Cookies policy